Obesity emerges as key driver of rising cancer rates in under-50s, study finds

Something has shifted in the landscape of cancer in Britain. Over the past two decades, doctors and researchers have watched with growing unease as cancer diagnoses in people under fifty have climbed steadily upward. In 2023 alone, roughly 31,000 people between twenty and forty-nine received a cancer diagnosis in England—about one in every thousand people in that age group. Breast cancer led the count at 8,500 cases, followed by bowel cancer at 3,000 and melanoma at 2,800. The pattern is unmistakable, and now scientists think they have found a significant piece of the puzzle: obesity.

A major study from researchers at the Institute of Cancer Research in London and Imperial College London examined nearly two decades of national cancer registry data and found something counterintuitive. The traditional culprits—smoking, alcohol consumption, processed meat, sedentary living—have either held steady or actually declined in the years leading up to these diagnoses. Yet cancer rates in young adults have gone up anyway. The one factor that has moved in the opposite direction, climbing steadily since 1995, is body weight. The connection is strong enough that the team believes excess weight plays a meaningful role, likely through mechanisms like elevated insulin levels and chronic inflammation that can fuel tumor growth.

But here is where the story becomes more complicated. Obesity, while important, does not tell the whole story. When researchers looked specifically at bowel cancer in younger women, they found that cases linked to weight gain were rising faster than cases unrelated to weight. Yet even accounting for this acceleration, the total number of weight-related cases remained smaller than those driven by other factors entirely. For bowel cancer alone, researchers estimate that roughly fifteen percent of cases in younger people stem from being overweight or obese, with another twenty-five to thirty-five percent attributable to other known risk factors like lack of exercise, alcohol, and smoking combined. That leaves a substantial gap—more than half the cases—unexplained.

Professor Montse Garcia-Closas, one of the study's lead researchers, described the mystery this way: the increase is likely not the work of a single hidden cause, but rather a combination of multiple factors working together in ways scientists do not yet fully understand. Other suspected contributors have emerged in recent years—ultra-processed foods, changes in antibiotic use, air pollution—but many of these have shown stable or even declining trends in the UK, which only deepens the puzzle. The researchers are calling for large, long-term studies to map out all the biological and environmental factors at play.

Yet they are not waiting for perfect answers before sounding the alarm. Professor Marc Gunter from Imperial College noted that obesity is a known risk factor for around nineteen different cancers. The mechanism appears to involve hormonal pathways: people with obesity tend to have elevated insulin levels, and insulin acts as a growth factor that has been linked to cancer development. Recent research suggests insulin may play a particular role in early-onset bowel cancer, an area of intense current investigation. The evidence is strong enough, the team argues, that obesity should become a public health priority—particularly efforts to reduce obesity rates in children and young people before patterns become entrenched.

The scale of the problem is worth holding in mind. In 2023, roughly one in every hundred people aged fifty to seventy-nine received a cancer diagnosis, compared to one in a thousand for those under fifty. Cancer in young adults remains statistically rare. But the trend is real, and it is moving in the wrong direction. Most of the eleven cancers identified as rising in younger adults—including thyroid, liver, kidney, pancreatic, endometrial, and ovarian cancers—are linked to excess weight. Only oral cancer among the eleven does not show this connection.

Michelle Mitchell, chief executive of Cancer Research UK, acknowledged both the clarity and the complexity of the findings. Improvements in detection and screening are likely playing a role too, she noted, meaning some of the increase reflects earlier diagnosis rather than purely higher incidence. Smoking remains the leading preventable cause of cancer in adults under fifty, which is why recent tobacco legislation matters. But the obesity connection is real enough that measures to restrict junk food advertising, improve access to nutritious food, and make healthy eating more affordable could meaningfully slow the rise.

Garcia-Closas put it plainly: we cannot wait for complete understanding before we act. The case for treating obesity as a cancer prevention priority is already strong. What remains is the harder work—not just identifying the missing pieces of this puzzle, but building the public health infrastructure and political will to actually change the trajectory. The young people being diagnosed today are the first generation to grow up in an environment of widespread obesity. Whether that pattern can be reversed may depend on decisions made in the next few years.